Pediatric Health Dispatch, September 8, 2026

Pear Suite, $900,000 grant from Health Net.

Health Net announced on August 25 that it awarded Pear Suite $900,000 to help California community-based organizations build technology infrastructure, enroll as Medi-Cal providers, and get reimbursed for community health worker and doula services. Read the buyer, not the amount. Health Net is Centene's California plan, which makes this a managed care organization writing a check for the administrative layer behind a benefit it already has to cover. That has not happened before in this category in a way we have been able to point at. Every dollar we have tracked into Medicaid doula and community health worker delivery over the past eighteen months went to networks: recruit doulas, train doulas, match doulas to patients. Virginia measured what that produces when the plumbing is missing, and the number was doula care in fewer than one percent of Medicaid births, with fewer than half of the state's 130 certified doula Medicaid providers ever submitting a single claim. Pear Suite sells the plumbing. Health Net says it has now committed more than $1.9 million to Pear Suite since 2023, which is the detail that turns a grant into a thesis. A one-time grant is charity. A third round of funding into the same vendor is a plan concluding that the constraint on its own benefit spend is administrative.

Luma Health + PCC, pediatric practice communications partnership, terms undisclosed.

Luma Health announced on August 19 that its communications platform is now natively integrated into Physician's Computer Company, the pediatrics-specific EHR, extending two-way multilingual family messaging to more than 300 independent pediatric practices and 1,400 pediatricians. The product is unremarkable and the distribution is not. Independent pediatrics is the most expensive channel in American healthcare to sell into, because it is thousands of small practices with no procurement function and no budget line for software that is not the EHR. PCC is one of the very few vendors built specifically for the specialty, which makes a native integration a way to reach a concentrated slice of that channel without a single practice-by-practice sale. Develo and its cohort argue that pediatrics needs a vertically integrated, pediatrics-native stack rebuilt from the ground up. Luma is making the opposite bet: pediatrics is a channel to be rented, not a vertical to be rebuilt. Both bets cannot be right. Watch whether PCC's independent practices actually turn on the messaging workflows.

Maven Clinic, high-risk pregnancy outcome benchmarks.

Not a financing, and worth the slot anyway, because it is the clearest statement yet of what a commercial maternity platform thinks it is selling. Maven published an outcomes note on August 26 reporting that among 979 members with high-risk pregnancies, those who attended virtual birth-planning appointments had 59% lower odds of NICU admission and were nearly four times more likely to report active involvement in labor and delivery decisions. In its broader high-risk benchmark set, Maven reported a 13.9% NICU admission rate against 20.4% nationally, and a 40.1% C-section rate against 44.4%. These are company-generated figures, not independent peer-reviewed research, and Maven's public materials do not separate the effect of birth-planning visits from the effect of general program engagement. Hold them loosely. Hold the strategy tightly, because NICU avoidance is the only maternity claim large enough to move an employer or a health plan budget, and Maven has stopped arguing about engagement and started arguing about the most expensive line item in the pregnancy.

Eyas Medical Imaging, Ascent3T neonatal MRI, FDA 510(k) clearance.

Seven months old and new to us, which is its own finding. Eyas received clearance on February 5 for the Ascent3T, described in public coverage as the first dedicated whole-body 3T MRI system built for neonate and infant anatomy and small enough to install inside the NICU. The company was conceived at Cincinnati Children's, was built on learning from more than 1,700 infant MRI scans on prototype systems, and draws electronics and pulse-sequence support from Philips. The clinical proposition is operational rather than diagnostic: stop transporting a fragile newborn down a corridor to a radiology suite designed for adults. The reason it belongs here is that it opens a sixth NICU infrastructure wedge our May 28 piece missed entirely. That piece sorted the category into wireless monitoring, nutrition, neuromonitoring, family workflow, and NICU-to-home, and argued that GE and Philips own the bedside while startups take everything around it. A NICU-sited 3T scanner is a startup making a claim directly on the bedside, with a Philips supply relationship rather than against one. The NICU market map is updated.

And that is the tape. One transaction in this window involved money changing hands for equity or assets, and it was a $900,000 grant from a health plan. The capital drought in maternal-pediatric venture has not broken, and we would rather report a payer grant as the lead than manufacture a fifth item. That is now four consecutive editions in which the most interesting money in this market came from a payer, a state, or a foundation rather than from a fund.

A federal judge blocked the Teen Pregnancy Prevention Program overhaul, and the mechanism is the story.

On August 19 a federal judge in the District of Columbia granted in part a preliminary injunction halting HHS's attempt to impose new conditions on the Teen Pregnancy Prevention Program, conditions that plaintiffs said would replace the program's evidence-based framework with abstinence-focused criteria. This is the third instance since early August of a federal action detaching an adolescent or pediatric service from its funding machinery without touching a coverage mandate. We called that category risk in the August 21 edition. What this case adds is a second variable: litigation. Blocking an action mid-grant-cycle does not restore planning certainty to an organization whose cooperative agreement was terminated in June, and a preliminary injunction is not a final judgment. For anyone selling into publicly funded adolescent health infrastructure, the procurement risk now includes the possibility that your customer's funding is legal, then illegal, then legal again, on a court's calendar rather than a fiscal one.

Ohio raised Medicaid prenatal rates and did not say by how much.

CMS approved Ohio state plan amendment OH-25-0026 on July 24 with a January 1, 2026 effective date, increasing payment rates for pregnancy and prenatal services. That is the second state in five weeks moving maternal or pediatric rates in the direction operators want. Here is the defect: the approval packet confirms rates went up and then points readers to Ohio's online fee schedules instead of publishing the revised values. Nobody outside the state can currently say whether this is a rounding adjustment or a repricing. An unquantified rate increase does not change a go-to-market plan, does not change a pro forma, and does not tell a maternal health company whether Ohio just became a market. The states are doing the thing we asked for. They are doing it invisibly.

The AAP asked for fair payment for lactation services, which makes three.

On August 3 the American Academy of Pediatrics published a policy statement on racial disparities in breastfeeding and human milk use, recommending four responses, of which one is commercial: secure fair payment for lactation services and supplies. As the third data point it is worth your attention. ACOG issued doula integration guidance on July 16. Arkansas passed a doula and lactation state plan amendment on July 22. The AAP now asks pediatricians to build community health worker partnerships and asks payers to fund lactation. Every one of these is a component service: real clinical value, no billable home under the global maternity bundle, chronically undersupplied as a direct result. The societies are endorsing these services clinically well ahead of any infrastructure that could buy them.

That's your Tuesday roundup. Thursday's deep dive: The Doula Coverage Trap. Twenty-six states plus DC now cover doula services in Medicaid, reimbursed between $459 and $1,500 per birth, and almost nobody uses them. The output is a diligence checklist for a category we have been measuring with the wrong metric.

Was this forwarded to you? Subscribe at pedshealthdispatch.com